AlsterrLab
AlsterrLab is a biotech-driven company based in Mainz, Germany, that combines biotechnology, polymer science, and textile engineering to create smart textiles for preventive healthcare.
Classification
Profile
Funding
Transforms everyday fabrics into functional smart textiles for preventive healthcare and wellness using biotechnology and polymer science.
B2B clients in the textile and healthcare industries seeking advanced functional yarns and fabric systems for wellness and performance.
- Product sales - therapeutic garments (unit price €80-€250)
Direct B2B sales team - targeting hospitals, rehab centers, and medical distributors (high-touch, consultative) · OEM partnerships - with established apparel brands (e.g., sportswear, compression-wear manufacturers) for co-branded product lines · Online D2C portal - limited SKU (e.g., pilot therapeutic socks) sold via own e-commerce site to gather
Local textile mill (Mainz) - for yarn extrusion and finishing · Medical sensor OEM - provides low-power pressure/temperature modules · University research labs - joint studies, access to clinical trial participants
R&D focused on biotechnology, polymer science, and textile engineering to develop proprietary functional yarns and fabric systems.
Expertise in biotechnology, polymer science, and textile engineering.
Combining biotechnology, polymer science, and textile engineering to develop next-generation smart textiles.
Dedicated account managers for hospitals & OEMs - quarterly health-outcome reviews, SLA-backed support · Subscription-based service for IoT data analytics (cloud platform, alerts, compliance reporting) · Community & education hub - webinars, whitepapers, and a developer API for third-party app integration
Competes in the smart textile and biotech wearable space; differentiates by combining biotechnology with textile engineering for preventive healthcare applications.
Need for functional fabrics that support preventive healthcare and wellness through advanced material science.
Regulatory positioning as a Class IIa medical device unlocks reimbursement routes, turning a price-sensitive market into a value-based o · Data-as-service creates recurring revenue that smooths cash-flow beyond one-off garment sales · IP licensing can scale revenue without proportional cost increase, especially once manufacturing is outsourced
Team details not yet available.
No investors recorded yet.